This online Key Insights™ activity from the 'Novel Targets for IBD Therapy: Is This the Final Frontier?' satellite symposium held during the 2017 Advances in IBD meeting, provides an expert commentary from Drs. Miguel D. Regueiro and Marla Dubinsky on the latest clinical trials, the newest data regarding the use of novel therapies for patients with IBD including their mechanisms of action, safety-efficacy profiles, and key issues that impact treatment decisions in day-to-day practice.

Earn CME credit for this activity at the following location:
[ Ссылка ]

© 2017 Imedex, LLC.

свернуть